Clinical Trials Finder hero image

Clinical Trials Finder

Clinical trials may offer you additional treatment options in addition to standard treatment options already available and approved to treat your cancer.

A common misconception is that clinical trials are only for people who have tried everything else and are out of options. In fact, a clinical trial may be the best option to treat your cancer at any stage of your cancer journey.

Not every clinical trial is available at every cancer center. Finding a clinical trial that may be an option for you can be difficult to navigate on your own. The KCA is proud to offer our new Clinical Trial Finder that may provide options for you close to home or anywhere in the United States. If a clinical trial that fits your cancer isn’t available now, one may be available in the future, so check back often. Talk to your doctor about clinical trials, including any that you find using the tool below.

The Clinical Trial Finder is intended for patients and caregivers for educational purposes only. Only your doctor can best advise if a clinical trial is appropriate for you. This tool uses information from clinicaltrials.gov and is updated monthly. KCA is not responsible for information provided to clinicaltrials.gov; complete trial information can be found on that website.

Find a Clinical Trial

Trials (154 Results)

Featured Trials

Title Lead Sponsor
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma Arcus Biosciences, Inc.

Trials

Title Lead Sponsor
Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Treatment of Newly Diagnosed Patient’s With Wilm’s Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation St. Jude Children’s Research Hospital
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma HiberCell, Inc.
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression A2 Biotherapeutics Inc.
Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) Children’s National Research Institute
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer National Cancer Institute (NCI)
Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus University of Texas Southwestern Medical Center
An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer Jonsson Comprehensive Cancer Center
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors Nationwide Children’s Hospital

Last updated: April 24, 2026

Keep Learning:

The Kidney Cancer Association provides educational literature for anyone impacted by kidney cancer.

Request your free copy today